APA (7th ed.) Citation

Yamamoto, Y., Carreras, J., Shimizu, T., Kakizaki, M., Kikuti, Y. Y., Roncador, G., . . . Kotani, A. (2022). Anti-HBV drug entecavir ameliorates DSS-induced colitis through PD-L1 induction. Pharmacological research, 179, 105918. https://doi.org/10.1016/j.phrs.2021.105918

Chicago Style (17th ed.) Citation

Yamamoto, Yuichiro, Joaquim Carreras, Takanobu Shimizu, Masatoshi Kakizaki, Yara Yukie Kikuti, Giovanna Roncador, Naoya Nakamura, and Ai Kotani. "Anti-HBV Drug Entecavir Ameliorates DSS-induced Colitis Through PD-L1 Induction." Pharmacological Research 179 (2022): 105918. https://doi.org/10.1016/j.phrs.2021.105918.

MLA (9th ed.) Citation

Yamamoto, Yuichiro, et al. "Anti-HBV Drug Entecavir Ameliorates DSS-induced Colitis Through PD-L1 Induction." Pharmacological Research, vol. 179, 2022, p. 105918, https://doi.org/10.1016/j.phrs.2021.105918.